Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16466823
[patent_doc_number] => 20200368360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => SKIN PERMEATION ENHANCING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/883625
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883625
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/883625 | SKIN PERMEATION ENHANCING COMPOSITION | May 25, 2020 | Pending |
Array
(
[id] => 16749916
[patent_doc_number] => 20210101925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => OXYSTEROLS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/879460
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/879460 | OXYSTEROLS AND METHODS OF USE THEREOF | May 19, 2020 | Abandoned |
Array
(
[id] => 16421894
[patent_doc_number] => 20200347092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/878329
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878329
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878329 | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof | May 18, 2020 | Issued |
Array
(
[id] => 17761360
[patent_doc_number] => 20220234972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => IRRADIATION PROCESS OF PRO VITAMIN D
[patent_app_type] => utility
[patent_app_number] => 17/609627
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609627
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609627 | IRRADIATION PROCESS OF PRO VITAMIN D | May 10, 2020 | Pending |
Array
(
[id] => 16420514
[patent_doc_number] => 20200345712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/864961
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864961
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864961 | Compositions and methods for treating cancer | Apr 30, 2020 | Issued |
Array
(
[id] => 16360965
[patent_doc_number] => 20200317716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => PREPARATION OF BILE ACIDS AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/856374
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16856374
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/856374 | Preparation of bile acids and intermediates thereof | Apr 22, 2020 | Issued |
Array
(
[id] => 16466655
[patent_doc_number] => 20200368192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => TREATMENT OF HYPERAMMONEMIA IN PATIENTS WITH RENAL INSUFFICIENCY
[patent_app_type] => utility
[patent_app_number] => 16/851999
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851999
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/851999 | TREATMENT OF HYPERAMMONEMIA IN PATIENTS WITH RENAL INSUFFICIENCY | Apr 16, 2020 | Abandoned |
Array
(
[id] => 16204729
[patent_doc_number] => 20200237719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => NONRACEMIC MIXTURES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/846905
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16846905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/846905 | Nonracemic mixtures and uses thereof | Apr 12, 2020 | Issued |
Array
(
[id] => 16310790
[patent_doc_number] => 20200289528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => Testosterone Ester Triglyceride Formulations
[patent_app_type] => utility
[patent_app_number] => 16/847067
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847067 | Testosterone ester triglyceride formulations | Apr 12, 2020 | Issued |
Array
(
[id] => 16671222
[patent_doc_number] => 20210059985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => METHOD FOR PREVENTING AND/OR TREATING AGING-ASSOCIATED COGNITIVE IMPAIRMENT AND NEUROINFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/844414
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16844414
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/844414 | METHOD FOR PREVENTING AND/OR TREATING AGING-ASSOCIATED COGNITIVE IMPAIRMENT AND NEUROINFLAMMATION | Apr 8, 2020 | Abandoned |
Array
(
[id] => 17997846
[patent_doc_number] => 11498940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Neuroactive steroids, compositions, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/843822
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46057
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843822
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843822 | Neuroactive steroids, compositions, and uses thereof | Apr 7, 2020 | Issued |
Array
(
[id] => 17058894
[patent_doc_number] => 11103475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Therapeutic compositions of undecylenic acid and arginine
[patent_app_type] => utility
[patent_app_number] => 16/836881
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 56
[patent_no_of_words] => 27559
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16836881
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/836881 | Therapeutic compositions of undecylenic acid and arginine | Mar 30, 2020 | Issued |
Array
(
[id] => 18517599
[patent_doc_number] => 11707469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Production of aspirin-triggered resolvins without the use of aspirin in a dietary omega-3 supplement
[patent_app_type] => utility
[patent_app_number] => 16/823739
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6742
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823739 | Production of aspirin-triggered resolvins without the use of aspirin in a dietary omega-3 supplement | Mar 18, 2020 | Issued |
Array
(
[id] => 17520503
[patent_doc_number] => 20220106352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PROCESS FOR THE PREPARATION OF FULVESTRANT 3-BORONIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/426689
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426689 | PROCESS FOR THE PREPARATION OF FULVESTRANT 3-BORONIC ACID | Mar 10, 2020 | Pending |
Array
(
[id] => 16389538
[patent_doc_number] => 20200330479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS
[patent_app_type] => utility
[patent_app_number] => 16/808278
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 318
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808278 | COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS | Mar 2, 2020 | Abandoned |
Array
(
[id] => 16582816
[patent_doc_number] => 20210017218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/800053
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800053
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800053 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | Feb 24, 2020 | Abandoned |
Array
(
[id] => 18186350
[patent_doc_number] => 11576908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Compositions for treating CMT and related disorders
[patent_app_type] => utility
[patent_app_number] => 16/786026
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 25
[patent_no_of_words] => 20060
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16786026
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/786026 | Compositions for treating CMT and related disorders | Feb 9, 2020 | Issued |
Array
(
[id] => 17020818
[patent_doc_number] => 20210244689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => METHOD OF TREATING POSTPRANDIAL INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/783775
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783775
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/783775 | METHOD OF TREATING POSTPRANDIAL INFLAMMATION | Feb 5, 2020 | Abandoned |
Array
(
[id] => 15963079
[patent_doc_number] => 20200165291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/778975
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16778975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/778975 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | Jan 30, 2020 | Abandoned |
Array
(
[id] => 15895043
[patent_doc_number] => 20200147040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => NONRACEMIC MIXTURES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/738261
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16738261
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/738261 | Nonracemic mixtures and uses thereof | Jan 8, 2020 | Issued |